Northern Trust Corp Cyclerion Therapeutics, Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	BUY	$1.56 - $2.99 $13,902 - $26,646	8,912 Added 12.4%	80,792 $139,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $19,830 - $30,000	7,264 Added 11.24%	71,880 $220,000
Q2 2021 Aug 13, 2021	SELL	$2.18 - $4.29 $380,189 - $748,171	-174,399 Reduced 72.97%	64,616 $252,000
Q1 2021 May 12, 2021	SELL	$2.69 - $5.12 $48,498 - $92,308	-18,029 Reduced 7.01%	239,015 $667,000
Q4 2020 Feb 11, 2021	SELL	$2.25 - $7.12 $20,360 - $64,428	-9,049 Reduced 3.4%	257,044 $787,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $67,992 - $164,871	19,651 Added 7.97%	266,093 $1.62 Million
Q2 2020 Aug 14, 2020	SELL	$2.37 - $7.14 $64,698 - $194,914	-27,299 Reduced 9.97%	246,442 $1.46 Million
Q1 2020 May 14, 2020	SELL	$2.46 - $5.84 $32,518 - $77,198	-13,219 Reduced 4.61%	273,741 $725,000
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $6,598 - $49,234	3,666 Added 1.29%	286,960 $780,000
Q3 2019 Nov 13, 2019	BUY	$8.12 - $14.54 $756,321 - $1.35 Million	93,143 Added 48.98%	283,294 $3.43 Million
Q2 2019 Aug 13, 2019	BUY	$9.6 - $22.85 $1.72 Million - $4.1 Million	179,477 Added 1681.44%	190,151 $2.18 Million
Q1 2019 May 13, 2019	BUY	$12.5 - $21.03 $133,425 - $224,474	10,674 New	10,674 $165,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.